Literature DB >> 19731910

Asymmetric synthesis of functionalized cyclopentanones via a multicatalytic secondary amine/N-heterocyclic carbene catalyzed cascade sequence.

Stephen P Lathrop1, Tomislav Rovis.   

Abstract

A one-pot, asymmetric multicatalytic formal [3+2] reaction between 1,3-dicarbonyls and alpha,beta-unsaturated aldehydes is described. The multicatalytic process involves a secondary amine catalyzed Michael addition followed by a N-heterocyclic carbene catalyzed intramolecular crossed benzoin reaction to afford densely functionalized cyclopentanones with high enantioselectivities. The reaction proceeds with a variety of alkyl and aryl enals as well as a range of 1,3-dicarbonyls (diketones and beta-ketoesters). The functionalized products are obtained from cheap, readily available starting materials in a rapid and efficient manner in a one-pot, one-step operation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19731910      PMCID: PMC2785226          DOI: 10.1021/ja905342e

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  44 in total

1.  A new approach for an organocatalytic multicomponent domino asymmetric reaction.

Authors:  Armando Carlone; Silvia Cabrera; Mauro Marigo; Karl Anker Jørgensen
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

2.  One-pot organocatalytic domino Michael-aldol and intramolecular SN2 reactions. Asymmetric synthesis of highly functionalized epoxycyclohexanone derivatives.

Authors:  Mauro Marigo; Søren Bertelsen; Aitor Landa; Karl Anker Jørgensen
Journal:  J Am Chem Soc       Date:  2006-04-26       Impact factor: 15.419

Review 3.  Asymmetric enamine catalysis.

Authors:  Santanu Mukherjee; Jung Woon Yang; Sebastian Hoffmann; Benjamin List
Journal:  Chem Rev       Date:  2007-12       Impact factor: 60.622

4.  Asymmetric organocatalytic domino Michael/aldol reactions: enantioselective synthesis of chiral cycloheptanones, tetrahydrochromenones, and polyfunctionalized bicyclo[3.2.1]octanes.

Authors:  Magnus Rueping; Alexander Kuenkel; Francisco Tato; Jan W Bats
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

5.  Catalytic asymmetric oxa-Michael-Michael cascade for facile construction of chiral chromans via an aminal intermediate.

Authors:  Liansuo Zu; Shilei Zhang; Hexin Xie; Wei Wang
Journal:  Org Lett       Date:  2009-04-02       Impact factor: 6.005

6.  Enantioselective organo-cascade catalysis.

Authors:  Yong Huang; Abbas M Walji; Catharine H Larsen; David W C MacMillan
Journal:  J Am Chem Soc       Date:  2005-11-02       Impact factor: 15.419

7.  A simple asymmetric organocatalytic approach to optically active cyclohexenones.

Authors:  Armando Carlone; Mauro Marigo; Chris North; Aitor Landa; Karl Anker Jørgensen
Journal:  Chem Commun (Camb)       Date:  2006-10-05       Impact factor: 6.222

8.  Catalytic intramolecular crossed aldehyde--ketone benzoin reactions: a novel synthesis of functionalized preanthraquinones.

Authors:  Yoshifumi Hachisu; Jeffrey W Bode; Keisuke Suzuki
Journal:  J Am Chem Soc       Date:  2003-07-16       Impact factor: 15.419

9.  Asymmetric organic catalysis with modified cinchona alkaloids.

Authors:  Shi-Kai Tian; Yonggang Chen; Jianfeng Hang; Liang Tang; Paul McDaid; Li Deng
Journal:  Acc Chem Res       Date:  2004-08       Impact factor: 22.384

10.  Organocatalytic asymmetric Michael reaction of cyclic 1,3-dicarbonyl compounds and alpha,beta-unsaturated ketones--a highly atom-economic catalytic one-step formation of optically active warfarin anticoagulant.

Authors:  Nis Halland; Tore Hansen; Karl Anker Jørgensen
Journal:  Angew Chem Int Ed Engl       Date:  2003-10-20       Impact factor: 15.336

View more
  22 in total

1.  Multicatalytic, asymmetric Michael/Stetter reaction of salicylaldehydes and activated alkynes.

Authors:  Claire M Filloux; Stephen P Lathrop; Tomislav Rovis
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-16       Impact factor: 11.205

Review 2.  Organocatalytic cascade reactions as a new tool in total synthesis.

Authors:  Christoph Grondal; Matthieu Jeanty; Dieter Enders
Journal:  Nat Chem       Date:  2010-02-19       Impact factor: 24.427

3.  An asymmetric synthesis of 1,2,4-trioxane anticancer agents via desymmetrization of peroxyquinols through a Brønsted acid catalysis cascade.

Authors:  David M Rubush; Michelle A Morges; Barbara J Rose; Douglas H Thamm; Tomislav Rovis
Journal:  J Am Chem Soc       Date:  2012-08-07       Impact factor: 15.419

Review 4.  Organocatalytic Reactions Enabled by N-Heterocyclic Carbenes.

Authors:  Darrin M Flanigan; Fedor Romanov-Michailidis; Nicholas A White; Tomislav Rovis
Journal:  Chem Rev       Date:  2015-05-20       Impact factor: 60.622

5.  Asymmetric N-Heterocyclic Carbene (NHC) Catalyzed Acyl Anion Reactivity.

Authors:  Harit U Vora; Tomislav Rovis
Journal:  Aldrichimica Acta       Date:  2011       Impact factor: 3.667

6.  Control of chemoselectivity in asymmetric tandem reactions: Direct synthesis of chiral amines bearing nonadjacent stereocenters.

Authors:  Zhe Li; Bin Hu; Yongwei Wu; Chao Fei; Li Deng
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-05       Impact factor: 11.205

7.  N-Heterocyclic Carbene and Chiral Brønsted Acid Cooperative Catalysis for a Highly Enantioselective [4+2] Annulation.

Authors:  Dian-Feng Chen; Tomislav Rovis
Journal:  Synthesis (Stuttg)       Date:  2016-11-18       Impact factor: 3.157

8.  Enamine/Carbene Cascade Catalysis in the Diastereo- and Enantioselective Synthesis of Functionalized Cyclopentanones.

Authors:  Kerem E Ozboya; Tomislav Rovis
Journal:  Chem Sci       Date:  2011-09-01       Impact factor: 9.825

9.  Cooperative Lewis acid/N-heterocyclic carbene catalysis.

Authors:  Daniel T Cohen; Karl A Scheidt
Journal:  Chem Sci       Date:  2012-01-01       Impact factor: 9.825

10.  Catalytic asymmetric cross-aza-benzoin reactions of aliphatic aldehydes with N-Boc-protected imines.

Authors:  Daniel A DiRocco; Tomislav Rovis
Journal:  Angew Chem Int Ed Engl       Date:  2012-05-04       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.